Michael Sarap, MD
Surgery · Cambridge, OHNPI 1275615296
Payments from drug & device makers
Across 40 payments — averaging $38.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$461
- Vector Surgical, LLC$450
- Merck$195
- Phathom Pharmaceuticals, Inc.$58
- Boston Scientific$53
- Takeda Pharmaceuticals U.S.A., Inc.$38
- plus $277 from 12 others
What the payments were for
- Consulting fees$45029%
- Food & beverage$1,08171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 3 | $461 |
| Vector Surgical, LLC | 3 | $450 |
| Merck | 12 | $195 |
| Phathom Pharmaceuticals, Inc. | 2 | $58 |
| Boston Scientific | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Stryker | 1 | $37 |
| Pacira Pharmaceuticals Incorporated | 2 | $37 |
| Smith+Nephew | 2 | $37 |
| Sanofi | 2 | $34 |
| Davol Inc. | 2 | $23 |
| Distalmotion US | 1 | $20 |
| Covidien LP | 1 | $18 |
| Olympus America Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Baxter Healthcare | 1 | $14 |
| Shire North American Group Inc | 1 | $12 |
| Kerecis Limited | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,531 in reported general payments places this provider in the 45th percentile of 988 surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 13 | $10,644 |
| Sucralfate | 71 | $2,780 |
| Omeprazole | 205 | $1,044 |
| Dicyclomine Hcl | 35 | $559 |
| Hydrocortisone | 24 | $193 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 52 | $188 |
| Procto-Med HcHydrocortisone | 11 | $145 |
| Famotidine | 22 | $116 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $108 |
| Metoclopramide Hcl | 35 | $98 |
| Pantoprazole Sodium | 23 | $88 |
Paid to pharmacies, not to this prescriber.
Other surgery in Cambridge
- Jonathan ThompsonWest Chester$2.2M
- Raymond OndersCleveland$1.2M
- Clayton PetroCleveland$1.1M
- Ali AminianCleveland$1.1M
- Michael RosenCleveland$983K
- Michael MearaColumbus$868K
- Neilendu KunduCleveland$808K
- Chase WehrleCleveland$741K
- Ihya GorgunCleveland$704K
- Craig JarrettCleveland$622K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.